Cargando…

Tackling Immune Targets for Breast Cancer: Beyond PD-1/PD-L1 Axis

The burden of breast cancer is imposing a huge global problem. Drug discovery research and novel approaches to treat breast cancer have been carried out extensively over the last decades. Although immune checkpoint inhibitors are showing promising preclinical and clinical results in treating breast...

Descripción completa

Detalles Bibliográficos
Autores principales: Tabana, Yasser, Okoye, Isobel S., Siraki, Arno, Elahi, Shokrollah, Barakat, Khaled H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973280/
https://www.ncbi.nlm.nih.gov/pubmed/33747948
http://dx.doi.org/10.3389/fonc.2021.628138